v3.26.1
Stockholders' Equity
 3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Stockholders' Equity Stockholders’ Equity
Common Stock — Our authorized capital stock consists of 60,000,000 shares of common stock with a par value of $0.01 per share; of which, 34,552,217 and 34,185,682 shares were issued and outstanding as of March 31, 2026 and December 31, 2025, respectively.
Preferred Stock — Our authorized capital stock also consists of 5,000,000 shares of preferred stock with a par value of $0.01 per share, with no preferred shares outstanding as of March 31, 2026 and December 31, 2025.
Earnings (Loss) Per Share — Basic earnings (loss) per share is determined by dividing net income (loss) by the weighted average number of common shares outstanding during the year. Diluted earnings (loss) per share presented is determined by
dividing net income (loss) by the weighted average number of common shares and potential common shares outstanding during the period as determined by the treasury stock method. Potential common shares are included in the diluted earnings per share calculation when dilutive.
Diluted earnings (loss) per share for the three months ended March 31, 2026 and 2025 includes the effect of potential common shares issuable when dilutive, and is as follows:
Three Months Ended March 31,
20262025
Net income (loss)$902 $(4,312)
Net income (loss) from continuing operations902 (3,139)
Net income (loss) from discontinued operations— (1,173)
Weighted average number of common shares outstanding (in '000s)34,190 33,693 
Dilutive effect of restricted stock grants after application of the Treasury Stock Method (in '000s)1,321 — 
Dilutive shares outstanding35,511 33,693 
Basic earnings (loss) per share from continuing operations$0.03 $(0.09)
Basic earnings (loss) per share from discontinued operations$— $(0.03)
Diluted earnings (loss) per share from continuing operations$0.03 $(0.09)
Diluted earnings (loss) per share from discontinued operations$— $(0.03)
There were 262 thousand outstanding shares of restricted stock awarded that were excluded from the calculation of diluted earnings (loss) per share for the three months ended March 31, 2026 and 646 thousand outstanding shares of restricted stock awarded that were excluded from the calculation of diluted earnings (loss) per share for the three months ended March 31, 2025.